Enkay Pharma Consulting Limited
06999699
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/08/2025
micro entity
Next accounts due
31/05/2027
Confirmation statement
Last: 02/08/2025
Due 16/08/2026
Industry
Officers
director · Since 25/08/2009
MEDICAL PRACTITIONER
BRITISH · ENGLAND · Age 71
Persons with Significant Control
Dr Hamida Koppiker
British · England · Age 72
115-116 Spon End, Spon End, Coventry, CV1 3HF
Notified 25/08/2016
Dr Nandan Parmanand Koppiker
British · England · Age 71
115-116, Spon End, Coventry, CV1 3HF
Notified 18/10/2017
CompanyRankvs 7142+ SIC 86220 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2025
Net Worth
£376k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£11k
Working capital
Current Assets
£23k
Current Liabilities
£34k
Fixed Assets
£388k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.68 | +£5k |
| 2024 | 0.33 | -£1k |
| 2023 | 0.13 | -£4k |
| 2022 | 4.11 | +£3k |
| 2021 | 2.98 | -£8k |
| 2020 | 5.54 | +£4k |
| 2019 | 5.80 | — |
Derived from filed accounts. Not audited figures.